BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 37122536)

  • 21. Serum microRNA-21 as a potential diagnostic biomarker for breast cancer: a systematic review and meta-analysis.
    Li S; Yang X; Yang J; Zhen J; Zhang D
    Clin Exp Med; 2016 Feb; 16(1):29-35. PubMed ID: 25516467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic value of circulating microRNAs in thyroid carcinoma: A systematic review and meta-analysis.
    Xu SL; Tian YY; Zhou Y; Liu LQ
    Clin Endocrinol (Oxf); 2020 Oct; 93(4):489-498. PubMed ID: 32379941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive power of circulating miRNAs in detecting colorectal cancer.
    Zeng W; Tu Y; Zhu Y; Wang Z; Li C; Lao L; Wu G
    Tumour Biol; 2015 Apr; 36(4):2559-67. PubMed ID: 25527153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating miRNAs as novel potential biomarkers for esophageal squamous cell carcinoma diagnosis: a meta-analysis update.
    Liu F; Tian T; Xia LL; Ding Y; Cormier RT; He Y
    Dis Esophagus; 2017 Feb; 30(2):1-9. PubMed ID: 27003597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis of the diagnostic value of exosomal miR-21 as a biomarker for the prediction of cancer.
    Liu F; Mao H; Chai S; Mao H
    J Clin Lab Anal; 2021 Oct; 35(10):e23956. PubMed ID: 34492742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic Value of Fecal MicroRNAs for Colorectal Cancer: a Meta-Analysis.
    Wang C; Zhao K; Rong Q
    Clin Lab; 2015; 61(12):1845-53. PubMed ID: 26882806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis.
    Huang YK; Yu JC; Kang WM; Ma ZQ; Ye X; Tian SB; Yan C
    PLoS One; 2015; 10(11):e0142080. PubMed ID: 26556485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-21 and microRNA-30c as diagnostic biomarkers for prostate cancer: a meta-analysis.
    Zhou H; Zhu X
    Cancer Manag Res; 2019; 11():2039-2050. PubMed ID: 30881128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic Value of MicroRNA-18a for Gastric Cancer: a Meta-Analysis.
    Liang Q; Zhang G; Wang J; Sheng S
    Clin Lab; 2018 Jan; 64(1):177-184. PubMed ID: 29479894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential role of microRNA-126 in the diagnosis of cancers: A systematic review and meta-analysis.
    Yan J; Ma S; Zhang Y; Yin C; Zhou X; Zhang G
    Medicine (Baltimore); 2016 Aug; 95(35):e4644. PubMed ID: 27583885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating MicroRNA-499 as a Diagnostic Biomarker for Acute Myocardial Infarction: A Meta-analysis.
    Zhao J; Yu H; Yan P; Zhou X; Wang Y; Yao Y
    Dis Markers; 2019; 2019():6121696. PubMed ID: 31191754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic accuracy of circulating microRNAs for hepatitis C virus-associated hepatocellular carcinoma: a systematic review and meta-analysis.
    Huang Y; Chen Y; Tu S; Zhang J; Qiu Y; Yu W
    BMC Infect Dis; 2022 Apr; 22(1):323. PubMed ID: 35365115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of circulating microRNA-21 expression in esophageal, pancreatic and colorectal cancers; a systematic review and meta-analysis.
    Guraya S
    Int J Surg; 2018 Dec; 60():41-47. PubMed ID: 30336280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Panels of circulating microRNAs as potential diagnostic biomarkers for breast cancer: a systematic review and meta-analysis.
    Nguyen THN; Nguyen TTN; Nguyen TTM; Nguyen LHM; Huynh LH; Phan HN; Nguyen HT
    Breast Cancer Res Treat; 2022 Nov; 196(1):1-15. PubMed ID: 36085533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CircRNAs as promising biomarker in diagnosis of breast cancer: An updated meta-analysis.
    Chu M; Fang Y; Jin Y
    J Clin Lab Anal; 2021 Sep; 35(9):e23934. PubMed ID: 34331339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Potential Diagnostic Accuracy of Circulating MicroRNAs for Leukemia: A Meta-Analysis.
    Zhang WT; Zhang GX; Gao SS
    Technol Cancer Res Treat; 2021; 20():15330338211011958. PubMed ID: 33902358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-92a as a potential biomarker in diagnosis of colorectal cancer: a systematic review and meta-analysis.
    Yang X; Zeng Z; Hou Y; Yuan T; Gao C; Jia W; Yi X; Liu M
    PLoS One; 2014; 9(2):e88745. PubMed ID: 24551148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic value of circulating microRNAs for osteosarcoma in Asian populations: a meta-analysis.
    Wang X; Ning Y; Yang L; Liu H; Wu C; Wang S; Guo X
    Clin Exp Med; 2017 May; 17(2):175-183. PubMed ID: 27106278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of circulating microRNA biomarkers for breast cancer detection: a meta-analysis.
    Liu L; Wang S; Cao X; Liu J
    Tumour Biol; 2014 Dec; 35(12):12245-53. PubMed ID: 25195131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic and prognostic value of microRNA-628 for cancers.
    Li JH; Sun SS; Fu CJ; Zhang AQ; Wang C; Xu R; Xie SY; Wang PY
    J Cancer; 2018; 9(9):1623-1634. PubMed ID: 29760801
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.